Table 2.
Percentage of counts from the whole body counts obtained for regions of interest drawn over the liver, lungs, kidney, spleen, and sacrum for the 38 patients treated with 90Y- ibritumomab tiuxetan.
| Lungs 24h | Lungs 48h | Kidneys 24h | Kidneys 48h | Liver 24h | Liver 48h | Spleen 24h | Spleen 48h | Sacrum 24h | Sacrum 48h | |
|---|---|---|---|---|---|---|---|---|---|---|
| Max | 6.4 | 5 | 3.1 | 3.1 | 62 | 32.75 | 10.75 | 14.09 | 4 | 3.2 |
| Min | 1.3 | 1.5 | 0.22 | 0.7 | 5.3 | 6 | 0.7 | 0.6 | 0.5 | 0.5 |
| Median | 3.8 | 2.9 | 1.9 | 1.885 | 9.25 | 9.8 | 1.9 | 2.2 | 1.2 | 1.35 |
| Mean | 3.75 | 3.10 | 1.89 | 1.84 | 10.97 | 11.09 | 2.97 | 3.11 | 1.46 | 1.53 |